FGF21 and Insulin resistance: One‐time administration of these vectors to obese animals enabled a long‐lasting increase in FGF21 levels in circulation, which resulted in sustained counteraction of obesity, adipose tissue inflammation, insulin resistance, and NASH in the absence of adverse events.